Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 4
1998 4
1999 3
2000 8
2001 1
2002 5
2003 11
2004 10
2005 10
2006 5
2007 8
2008 8
2009 4
2010 5
2011 12
2012 8
2013 5
2014 8
2015 14
2016 4
2017 5
2018 7
2019 11
2020 12
2021 7
2022 10
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Keskiniva
Page 1
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
Malani D, Kumar A, Brück O, Kontro M, Yadav B, Hellesøy M, Kuusanmäki H, Dufva O, Kankainen M, Eldfors S, Potdar S, Saarela J, Turunen L, Parsons A, Västrik I, Kivinen K, Saarela J, Räty R, Lehto M, Wolf M, Gjertsen BT, Mustjoki S, Aittokallio T, Wennerberg K, Heckman CA, Kallioniemi O, Porkka K. Malani D, et al. Cancer Discov. 2022 Feb;12(2):388-401. doi: 10.1158/2159-8290.CD-21-0410. Epub 2021 Nov 17. Cancer Discov. 2022. PMID: 34789538 Free PMC article.
Neuropathology of viral infections.
Hatanpaa KJ, Kim JH. Hatanpaa KJ, et al. Handb Clin Neurol. 2014;123:193-214. doi: 10.1016/B978-0-444-53488-0.00008-0. Handb Clin Neurol. 2014. PMID: 25015486 Review. No abstract available.
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
Bulten W, Kartasalo K, Chen PC, Ström P, Pinckaers H, Nagpal K, Cai Y, Steiner DF, van Boven H, Vink R, Hulsbergen-van de Kaa C, van der Laak J, Amin MB, Evans AJ, van der Kwast T, Allan R, Humphrey PA, Grönberg H, Samaratunga H, Delahunt B, Tsuzuki T, Häkkinen T, Egevad L, Demkin M, Dane S, Tan F, Valkonen M, Corrado GS, Peng L, Mermel CH, Ruusuvuori P, Litjens G, Eklund M; PANDA challenge consortium. Bulten W, et al. Nat Med. 2022 Jan;28(1):154-163. doi: 10.1038/s41591-021-01620-2. Epub 2022 Jan 13. Nat Med. 2022. PMID: 35027755 Free PMC article.
Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type?
Kettunen K, Boström P, Taimen P. Kettunen K, et al. Eur Urol. 2020 Jan;77(1):e23. doi: 10.1016/j.eururo.2019.09.011. Epub 2019 Sep 26. Eur Urol. 2020. PMID: 31564578 No abstract available.
Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4.
Kettunen K, Boström PJ, Taimen P. Kettunen K, et al. Eur Urol. 2019 Nov;76(5):e137-e138. doi: 10.1016/j.eururo.2019.07.049. Epub 2019 Aug 13. Eur Urol. 2019. PMID: 31420250 No abstract available.
178 results